The global market for Therapeutic Vaccines was valued at US$ 45320 million in the year 2024 and is projected to reach a revised size of US$ 165000 million by 2031, growing at a CAGR of 20.6% during the forecast period.

Therapeutic Vaccines Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Therapeutic Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Vaccines.

The Therapeutic Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Therapeutic Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Therapeutic Vaccines Market Report

Report Metric	Details
Report Name	Therapeutic Vaccines Market
Accounted market size in year	US$ 45320 million
Forecasted market size in 2031	US$ 165000 million
CAGR	20.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Peptide Therapeutic Vaccine Cell Therapeutic Vaccine Nucleic Acid Therapeutic Vaccine
Segment by Application	Oncotherapy Hepatitis B Tuberculosis Herpes Simplex Virus Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Northeast Biotherapeutics, Agenus, Vaccinogen Inc, CIMAB S.A, Dendreon, Corixa, AVAX Technologies
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Therapeutic Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Therapeutic Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Therapeutic Vaccines Market growing?

Ans: The Therapeutic Vaccines Market witnessing a CAGR of 20.6% during the forecast period 2025-2031.

What is the Therapeutic Vaccines Market size in 2031?

Ans: The Therapeutic Vaccines Market size in 2031 will be US$ 165000 million.

Who are the main players in the Therapeutic Vaccines Market report?

Ans: The main players in the Therapeutic Vaccines Market are Northeast Biotherapeutics, Agenus, Vaccinogen Inc, CIMAB S.A, Dendreon, Corixa, AVAX Technologies

What are the Application segmentation covered in the Therapeutic Vaccines Market report?

Ans: The Applications covered in the Therapeutic Vaccines Market report are Oncotherapy, Hepatitis B, Tuberculosis, Herpes Simplex Virus, Others

What are the Type segmentation covered in the Therapeutic Vaccines Market report?

Ans: The Types covered in the Therapeutic Vaccines Market report are Peptide Therapeutic Vaccine, Cell Therapeutic Vaccine, Nucleic Acid Therapeutic Vaccine

1 Therapeutic Vaccines Market Overview

1.1 Product Definition

1.2 Therapeutic Vaccines by Type

1.2.1 Global Therapeutic Vaccines Market Value Comparison by Type (2024 VS 2031)

1.2.2 Peptide Therapeutic Vaccine

1.2.3 Cell Therapeutic Vaccine

1.2.4 Nucleic Acid Therapeutic Vaccine

1.3 Therapeutic Vaccines by Application

1.3.1 Global Therapeutic Vaccines Market Value by Application (2024 VS 2031)

1.3.2 Oncotherapy

1.3.3 Hepatitis B

1.3.4 Tuberculosis

1.3.5 Herpes Simplex Virus

1.3.6 Others

1.4 Global Therapeutic Vaccines Market Size Estimates and Forecasts

1.4.1 Global Therapeutic Vaccines Revenue 2020-2031

1.4.2 Global Therapeutic Vaccines Sales 2020-2031

1.4.3 Global Therapeutic Vaccines Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Therapeutic Vaccines Market Competition by Manufacturers

2.1 Global Therapeutic Vaccines Sales Market Share by Manufacturers (2020-2025)

2.2 Global Therapeutic Vaccines Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Therapeutic Vaccines Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Therapeutic Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Therapeutic Vaccines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Therapeutic Vaccines, Product Type & Application

2.7 Global Key Manufacturers of Therapeutic Vaccines, Date of Enter into This Industry

2.8 Global Therapeutic Vaccines Market Competitive Situation and Trends

2.8.1 Global Therapeutic Vaccines Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Therapeutic Vaccines Players Market Share by Revenue

2.8.3 Global Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Therapeutic Vaccines Market Scenario by Region

3.1 Global Therapeutic Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Therapeutic Vaccines Sales by Region: 2020-2031

3.2.1 Global Therapeutic Vaccines Sales by Region: 2020-2025

3.2.2 Global Therapeutic Vaccines Sales by Region: 2026-2031

3.3 Global Therapeutic Vaccines Revenue by Region: 2020-2031

3.3.1 Global Therapeutic Vaccines Revenue by Region: 2020-2025

3.3.2 Global Therapeutic Vaccines Revenue by Region: 2026-2031

3.4 North America Therapeutic Vaccines Market Facts & Figures by Country

3.4.1 North America Therapeutic Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Therapeutic Vaccines Sales by Country (2020-2031)

3.4.3 North America Therapeutic Vaccines Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Therapeutic Vaccines Market Facts & Figures by Country

3.5.1 Europe Therapeutic Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Therapeutic Vaccines Sales by Country (2020-2031)

3.5.3 Europe Therapeutic Vaccines Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Therapeutic Vaccines Market Facts & Figures by Region

3.6.1 Asia Pacific Therapeutic Vaccines Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Therapeutic Vaccines Sales by Region (2020-2031)

3.6.3 Asia Pacific Therapeutic Vaccines Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Therapeutic Vaccines Market Facts & Figures by Country

3.7.1 Latin America Therapeutic Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Therapeutic Vaccines Sales by Country (2020-2031)

3.7.3 Latin America Therapeutic Vaccines Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Therapeutic Vaccines Market Facts & Figures by Country

3.8.1 Middle East and Africa Therapeutic Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Therapeutic Vaccines Sales by Country (2020-2031)

3.8.3 Middle East and Africa Therapeutic Vaccines Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Therapeutic Vaccines Sales by Type (2020-2031)

4.1.1 Global Therapeutic Vaccines Sales by Type (2020-2025)

4.1.2 Global Therapeutic Vaccines Sales by Type (2026-2031)

4.1.3 Global Therapeutic Vaccines Sales Market Share by Type (2020-2031)

4.2 Global Therapeutic Vaccines Revenue by Type (2020-2031)

4.2.1 Global Therapeutic Vaccines Revenue by Type (2020-2025)

4.2.2 Global Therapeutic Vaccines Revenue by Type (2026-2031)

4.2.3 Global Therapeutic Vaccines Revenue Market Share by Type (2020-2031)

4.3 Global Therapeutic Vaccines Price by Type (2020-2031)

5 Segment by Application

5.1 Global Therapeutic Vaccines Sales by Application (2020-2031)

5.1.1 Global Therapeutic Vaccines Sales by Application (2020-2025)

5.1.2 Global Therapeutic Vaccines Sales by Application (2026-2031)

5.1.3 Global Therapeutic Vaccines Sales Market Share by Application (2020-2031)

5.2 Global Therapeutic Vaccines Revenue by Application (2020-2031)

5.2.1 Global Therapeutic Vaccines Revenue by Application (2020-2025)

5.2.2 Global Therapeutic Vaccines Revenue by Application (2026-2031)

5.2.3 Global Therapeutic Vaccines Revenue Market Share by Application (2020-2031)

5.3 Global Therapeutic Vaccines Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Northeast Biotherapeutics

6.1.1 Northeast Biotherapeutics Company Information

6.1.2 Northeast Biotherapeutics Description and Business Overview

6.1.3 Northeast Biotherapeutics Therapeutic Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Northeast Biotherapeutics Therapeutic Vaccines Product Portfolio

6.1.5 Northeast Biotherapeutics Recent Developments/Updates

6.2 Agenus

6.2.1 Agenus Company Information

6.2.2 Agenus Description and Business Overview

6.2.3 Agenus Therapeutic Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Agenus Therapeutic Vaccines Product Portfolio

6.2.5 Agenus Recent Developments/Updates

6.3 Vaccinogen Inc

6.3.1 Vaccinogen Inc Company Information

6.3.2 Vaccinogen Inc Description and Business Overview

6.3.3 Vaccinogen Inc Therapeutic Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Vaccinogen Inc Therapeutic Vaccines Product Portfolio

6.3.5 Vaccinogen Inc Recent Developments/Updates

6.4 CIMAB S.A

6.4.1 CIMAB S.A Company Information

6.4.2 CIMAB S.A Description and Business Overview

6.4.3 CIMAB S.A Therapeutic Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.4.4 CIMAB S.A Therapeutic Vaccines Product Portfolio

6.4.5 CIMAB S.A Recent Developments/Updates

6.5 Dendreon

6.5.1 Dendreon Company Information

6.5.2 Dendreon Description and Business Overview

6.5.3 Dendreon Therapeutic Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Dendreon Therapeutic Vaccines Product Portfolio

6.5.5 Dendreon Recent Developments/Updates

6.6 Corixa

6.6.1 Corixa Company Information

6.6.2 Corixa Description and Business Overview

6.6.3 Corixa Therapeutic Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Corixa Therapeutic Vaccines Product Portfolio

6.6.5 Corixa Recent Developments/Updates

6.7 AVAX Technologies

6.7.1 AVAX Technologies Company Information

6.7.2 AVAX Technologies Description and Business Overview

6.7.3 AVAX Technologies Therapeutic Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.7.4 AVAX Technologies Therapeutic Vaccines Product Portfolio

6.7.5 AVAX Technologies Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Therapeutic Vaccines Industry Chain Analysis

7.2 Therapeutic Vaccines Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Therapeutic Vaccines Production Mode & Process Analysis

7.4 Therapeutic Vaccines Sales and Marketing

7.4.1 Therapeutic Vaccines Sales Channels

7.4.2 Therapeutic Vaccines Distributors

7.5 Therapeutic Vaccines Customer Analysis

8 Therapeutic Vaccines Market Dynamics

8.1 Therapeutic Vaccines Industry Trends

8.2 Therapeutic Vaccines Market Drivers

8.3 Therapeutic Vaccines Market Challenges

8.4 Therapeutic Vaccines Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Northeast Biotherapeutics

List of Tables

Table 1. Global Therapeutic Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Therapeutic Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Therapeutic Vaccines Market Competitive Situation by Manufacturers in 2024

Table 4. Global Therapeutic Vaccines Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Therapeutic Vaccines Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Therapeutic Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Therapeutic Vaccines Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Therapeutic Vaccines Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Therapeutic Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Therapeutic Vaccines, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Therapeutic Vaccines, Product Type & Application

Table 12. Global Key Manufacturers of Therapeutic Vaccines, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Therapeutic Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Vaccines as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Therapeutic Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Therapeutic Vaccines Sales by Region (2020-2025) & (K Units)

Table 18. Global Therapeutic Vaccines Sales Market Share by Region (2020-2025)

Table 19. Global Therapeutic Vaccines Sales by Region (2026-2031) & (K Units)

Table 20. Global Therapeutic Vaccines Sales Market Share by Region (2026-2031)

Table 21. Global Therapeutic Vaccines Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Therapeutic Vaccines Revenue Market Share by Region (2020-2025)

Table 23. Global Therapeutic Vaccines Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Therapeutic Vaccines Revenue Market Share by Region (2026-2031)

Table 25. North America Therapeutic Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Therapeutic Vaccines Sales by Country (2020-2025) & (K Units)

Table 27. North America Therapeutic Vaccines Sales by Country (2026-2031) & (K Units)

Table 28. North America Therapeutic Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Therapeutic Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Therapeutic Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Therapeutic Vaccines Sales by Country (2020-2025) & (K Units)

Table 32. Europe Therapeutic Vaccines Sales by Country (2026-2031) & (K Units)

Table 33. Europe Therapeutic Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Therapeutic Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Therapeutic Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Therapeutic Vaccines Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Therapeutic Vaccines Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Therapeutic Vaccines Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Therapeutic Vaccines Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Therapeutic Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Therapeutic Vaccines Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Therapeutic Vaccines Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Therapeutic Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Therapeutic Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Therapeutic Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Therapeutic Vaccines Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Therapeutic Vaccines Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Therapeutic Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Therapeutic Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Therapeutic Vaccines Sales (K Units) by Type (2020-2025)

Table 51. Global Therapeutic Vaccines Sales (K Units) by Type (2026-2031)

Table 52. Global Therapeutic Vaccines Sales Market Share by Type (2020-2025)

Table 53. Global Therapeutic Vaccines Sales Market Share by Type (2026-2031)

Table 54. Global Therapeutic Vaccines Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Therapeutic Vaccines Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Therapeutic Vaccines Revenue Market Share by Type (2020-2025)

Table 57. Global Therapeutic Vaccines Revenue Market Share by Type (2026-2031)

Table 58. Global Therapeutic Vaccines Price (USD/Unit) by Type (2020-2025)

Table 59. Global Therapeutic Vaccines Price (USD/Unit) by Type (2026-2031)

Table 60. Global Therapeutic Vaccines Sales (K Units) by Application (2020-2025)

Table 61. Global Therapeutic Vaccines Sales (K Units) by Application (2026-2031)

Table 62. Global Therapeutic Vaccines Sales Market Share by Application (2020-2025)

Table 63. Global Therapeutic Vaccines Sales Market Share by Application (2026-2031)

Table 64. Global Therapeutic Vaccines Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Therapeutic Vaccines Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Therapeutic Vaccines Revenue Market Share by Application (2020-2025)

Table 67. Global Therapeutic Vaccines Revenue Market Share by Application (2026-2031)

Table 68. Global Therapeutic Vaccines Price (USD/Unit) by Application (2020-2025)

Table 69. Global Therapeutic Vaccines Price (USD/Unit) by Application (2026-2031)

Table 70. Northeast Biotherapeutics Company Information

Table 71. Northeast Biotherapeutics Description and Business Overview

Table 72. Northeast Biotherapeutics Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Northeast Biotherapeutics Therapeutic Vaccines Product

Table 74. Northeast Biotherapeutics Recent Developments/Updates

Table 75. Agenus Company Information

Table 76. Agenus Description and Business Overview

Table 77. Agenus Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Agenus Therapeutic Vaccines Product

Table 79. Agenus Recent Developments/Updates

Table 80. Vaccinogen Inc Company Information

Table 81. Vaccinogen Inc Description and Business Overview

Table 82. Vaccinogen Inc Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Vaccinogen Inc Therapeutic Vaccines Product

Table 84. Vaccinogen Inc Recent Developments/Updates

Table 85. CIMAB S.A Company Information

Table 86. CIMAB S.A Description and Business Overview

Table 87. CIMAB S.A Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. CIMAB S.A Therapeutic Vaccines Product

Table 89. CIMAB S.A Recent Developments/Updates

Table 90. Dendreon Company Information

Table 91. Dendreon Description and Business Overview

Table 92. Dendreon Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Dendreon Therapeutic Vaccines Product

Table 94. Dendreon Recent Developments/Updates

Table 95. Corixa Company Information

Table 96. Corixa Description and Business Overview

Table 97. Corixa Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Corixa Therapeutic Vaccines Product

Table 99. Corixa Recent Developments/Updates

Table 100. AVAX Technologies Company Information

Table 101. AVAX Technologies Description and Business Overview

Table 102. AVAX Technologies Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. AVAX Technologies Therapeutic Vaccines Product

Table 104. AVAX Technologies Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Therapeutic Vaccines Distributors List

Table 108. Therapeutic Vaccines Customers List

Table 109. Therapeutic Vaccines Market Trends

Table 110. Therapeutic Vaccines Market Drivers

Table 111. Therapeutic Vaccines Market Challenges

Table 112. Therapeutic Vaccines Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Therapeutic Vaccines

Figure 2. Global Therapeutic Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Therapeutic Vaccines Market Share by Type: 2024 & 2031

Figure 4. Peptide Therapeutic Vaccine Product Picture

Figure 5. Cell Therapeutic Vaccine Product Picture

Figure 6. Nucleic Acid Therapeutic Vaccine Product Picture

Figure 7. Global Therapeutic Vaccines Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Therapeutic Vaccines Market Share by Application: 2024 & 2031

Figure 9. Oncotherapy

Figure 10. Hepatitis B

Figure 11. Tuberculosis

Figure 12. Herpes Simplex Virus

Figure 13. Others

Figure 14. Global Therapeutic Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Therapeutic Vaccines Market Size (2020-2031) & (US$ Million)

Figure 16. Global Therapeutic Vaccines Sales (2020-2031) & (K Units)

Figure 17. Global Therapeutic Vaccines Average Price (USD/Unit) & (2020-2031)

Figure 18. Therapeutic Vaccines Report Years Considered

Figure 19. Therapeutic Vaccines Sales Share by Manufacturers in 2024

Figure 20. Global Therapeutic Vaccines Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Therapeutic Vaccines Players: Market Share by Revenue in Therapeutic Vaccines in 2024

Figure 22. Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Therapeutic Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Therapeutic Vaccines Sales Market Share by Country (2020-2031)

Figure 25. North America Therapeutic Vaccines Revenue Market Share by Country (2020-2031)

Figure 26. U.S. Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Therapeutic Vaccines Sales Market Share by Country (2020-2031)

Figure 29. Europe Therapeutic Vaccines Revenue Market Share by Country (2020-2031)

Figure 30. Germany Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Therapeutic Vaccines Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Therapeutic Vaccines Revenue Market Share by Region (2020-2031)

Figure 37. China Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. China Taiwan Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Therapeutic Vaccines Sales Market Share by Country (2020-2031)

Figure 47. Latin America Therapeutic Vaccines Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Therapeutic Vaccines Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Therapeutic Vaccines Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. UAE Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Therapeutic Vaccines by Type (2020-2031)

Figure 57. Global Revenue Market Share of Therapeutic Vaccines by Type (2020-2031)

Figure 58. Global Therapeutic Vaccines Price (USD/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Therapeutic Vaccines by Application (2020-2031)

Figure 60. Global Revenue Market Share of Therapeutic Vaccines by Application (2020-2031)

Figure 61. Global Therapeutic Vaccines Price (USD/Unit) by Application (2020-2031)

Figure 62. Therapeutic Vaccines Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions